Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 29, 2019
DAILY DOSE | A new cutting-edge cancer treatment has been developed in one of the innovation capitals of the world — Israel. How does it work and why is some of the medical community eagerly awaiting to use it? Accelerated Evolution Biotechnologies CEO Ilan Morad discusses with host Ayman Sikseck.
Has a cure for cancer finally been found? Maybe, and it may have born right here in Israel.
An Israeli team of scientists is developing an anti-cancer drug that will target several mutations in cancer cells using a combination of several-cancer directed peptides.
The treatment is called MuTaTo, or multi-objective toxin, and is essentially on the scale of a cancer antibiotic.